MX2014005404A - Composicion cosmetica. - Google Patents

Composicion cosmetica.

Info

Publication number
MX2014005404A
MX2014005404A MX2014005404A MX2014005404A MX2014005404A MX 2014005404 A MX2014005404 A MX 2014005404A MX 2014005404 A MX2014005404 A MX 2014005404A MX 2014005404 A MX2014005404 A MX 2014005404A MX 2014005404 A MX2014005404 A MX 2014005404A
Authority
MX
Mexico
Prior art keywords
cosmetic composition
vitamin
agent
skin
relates
Prior art date
Application number
MX2014005404A
Other languages
English (en)
Inventor
Ezat Khosdel
Qiqing Zhang
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of MX2014005404A publication Critical patent/MX2014005404A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/896Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/612By organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La invención se refiere a una composición cosmética comprendiendo una emulsión que comprende partículas hidrofóbicamente modificada, silicón amino funcionalizado y agua; la composición cosmética que comprende además un agente humectante y al menos un componente seleccionado del grupo que consiste de vitamina, agente anti-caspa y surfactante, en donde la composición comprende al menos una vitamina o agente anti-caspa. La invención se refiere además a un método para tratar una condición de la piel comprendiendo el paso de aplicar tópicamente a la piel la composición cosmética de la invención.
MX2014005404A 2011-11-04 2012-10-16 Composicion cosmetica. MX2014005404A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011081810 2011-11-04
PCT/EP2012/070485 WO2013064365A1 (en) 2011-11-04 2012-10-16 Cosmetic composition

Publications (1)

Publication Number Publication Date
MX2014005404A true MX2014005404A (es) 2014-06-23

Family

ID=47045027

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014005404A MX2014005404A (es) 2011-11-04 2012-10-16 Composicion cosmetica.

Country Status (7)

Country Link
US (1) US20140294974A1 (es)
EP (1) EP2773313A1 (es)
JP (1) JP2014532674A (es)
BR (1) BR112014010294A2 (es)
EA (1) EA030316B1 (es)
MX (1) MX2014005404A (es)
WO (1) WO2013064365A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011137563A1 (en) 2010-05-07 2011-11-10 Unilever Plc High solvent content emulsions
WO2015158499A1 (en) * 2014-04-14 2015-10-22 Unilever N.V. Personal care composition
US20170027836A1 (en) * 2014-04-14 2017-02-02 Conopco, Inc., D/B/A Unilever Personal care composition
DE102014222801A1 (de) * 2014-11-07 2016-05-12 Henkel Ag & Co. Kgaa Mittel und Verfahren zur temporären Verformung keratinhaltiger Fasern
BR112018072303B1 (pt) * 2016-05-11 2021-11-16 Unilever Ip Holdings B.V. Composiqao cosmetica e metodo para entregar impacto duradouro de perfumaria
WO2018008653A1 (ja) * 2016-07-05 2018-01-11 株式会社カネカ 乳化組成物及びそれを用いる化粧料
CN116634995A (zh) * 2020-12-30 2023-08-22 联合利华知识产权控股有限公司 毛发护理组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185087A (en) 1977-12-28 1980-01-22 Union Carbide Corporation Hair conditioning compositions containing dialkylamino hydroxy organosilicon compounds and their derivatives
GB9507130D0 (en) 1995-04-06 1995-05-31 Unilever Plc Hair treatment composition
GB2357497A (en) 1999-12-22 2001-06-27 Degussa Hydrophobic silica
JP4621554B2 (ja) * 2005-07-08 2011-01-26 花王株式会社 角栓除去剤組成物
JP5239122B2 (ja) * 2006-03-03 2013-07-17 信越化学工業株式会社 オルガノポリシロキサン粉体処理剤及び該処理剤により処理された粉体並びに該粉体を含有する化粧料
JP2008143820A (ja) * 2006-12-08 2008-06-26 Kao Corp 乳化化粧料
GB0813140D0 (en) * 2008-07-18 2008-08-27 Dow Corning Home and personal care compositions
CN105748320A (zh) * 2009-11-06 2016-07-13 雅芳产品公司 用于防止或减少毛发的毛躁外观的方法和组合物
JP5800823B2 (ja) * 2009-11-06 2015-10-28 エイボン プロダクツ インコーポレーテッド 毛髪の外観の縮れを予防または低減する方法および組成物
WO2011137563A1 (en) * 2010-05-07 2011-11-10 Unilever Plc High solvent content emulsions

Also Published As

Publication number Publication date
EP2773313A1 (en) 2014-09-10
JP2014532674A (ja) 2014-12-08
US20140294974A1 (en) 2014-10-02
WO2013064365A1 (en) 2013-05-10
BR112014010294A2 (pt) 2017-04-18
EA201400541A1 (ru) 2014-08-29
EA030316B1 (ru) 2018-07-31

Similar Documents

Publication Publication Date Title
MX2014005404A (es) Composicion cosmetica.
ZA201701460B (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles
EP4241758A3 (en) Anti-dandruff composition
MX2017003969A (es) Composiciones para el cuidado personal que comprenden composiciones para la reduccion del mal olor.
MX2018005829A (es) Composiciones para tratar el cabello.
IN2014DN09928A (es)
MX340250B (es) Espumas emolientes para el tratamiento de dermatosis.
NZ715201A (en) Afucosylated anti-fgfr2iiib antibodies
WO2014043696A3 (en) Compositions and methods for treating amyotrophic lateral sclerosis
EP3156037A4 (en) Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition
MX2017013538A (es) Metodos y composiciones concentradas para la limpieza personal.
MX2018008855A (es) Composicion que comprende toxina botulinica.
EP3156043A4 (en) A-gel-intermediate composition, and production method for a-gel-containing o/w emulsion cosmetic using said composition
WO2013006336A3 (en) Methods and compositions useful for treating fitzpatrick type iv, v or vi skin
MX2017014129A (es) Metodos para tratar con cosmeticos enfermedades de la piel con una composicion cosmetica limpiadora personal.
NZ706983A (en) Treating soluble coffee
NZ710602A (en) Methods for reducing pyrogenicity in a seaweed extract
WO2014026804A3 (de) Mittel und verfahren zur temporären verformung keratinhaltiger fasern
EP3471741A4 (en) PERSONALIZED COSMETIC COMPOSITIONS, AND METHODS OF REGENERATING AND USING CELLS AND / OR COMPONENTS THEREOF
MX2018007865A (es) Composiciones para el cuidado personal.
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
IN2014DE01913A (es)
WO2012104240A3 (de) Kosmetische verwendung
WO2013006558A3 (en) Compositions and methods for treating skeletal myopathy
MX2019011489A (es) Alimento y cosmeticos saludables para aumentar la cantidad de celulas apoptoticas y para disminuir la cantidad de celulas necroticas y un metodo de fabricacion de un ingrediente derivado de semilla de uva con crecimiento forzado de brotes para aumentar la cantidad de celulas apoptoticas y para disminuir la cantidad de celulas necroticas.